Skip to main content
. 2024 May 20;7:19. doi: 10.20517/cdr.2024.04

Table 2.

Fold change of the percentage of growth inhibition of the NSCLC cell lines following treatment with chemotherapeutic drugs combined with pentoxifylline vs. without pentoxifylline

NSCLC cell lines Combination treatment consisting of pentoxifylline with
Paclitaxel Vinorelbine Carboplatin Vinorelbine plus carboplatin
NCI-H460 2.14 1.33 1.86 1.78
NCI-H460/R 1.64 2.36 1.74 2.42
A549 1.5 1.25 1.41 1.62
A549-CDR2 1.23 1.53 1.19 1.43

NSCLC: Non-small cell lung cancer.